DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Orvepitant is an investigational drug.
There have been 8 clinical trials for Orvepitant. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2017.
The most common disease conditions in clinical trials are Disease, Depressive Disorder, Major, and Depressive Disorder. The leading clinical trial sponsors are GlaxoSmithKline, Nerre Therapeutics Ltd., and [disabled in preview].
Recent Clinical Trials for Orvepitant
|A Pharmacokinetic Study of the Effect of Itraconazole Exposure to Orvepitant in Healthy Volunteers||Nerre Therapeutics Ltd.||Phase 1|
|A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis||Nerre Therapeutics Ltd.||Phase 2|
|A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough||Nerre Therapeutics Ltd.||Phase 2|